FATE R&D Expenses
Fate Therapeutics Inc · R&D Expenses
FATE R&D Expenses
Latest reported$97.44Mperiod ending
FATE TTM R&D Expenses ($12.01M → $97.44M)
TTM R&D Expenses
High-resolution chart · PNG
FATE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 97,435,000 | |
| 100,478,000 | |
| 107,829,000 | |
| 116,013,000 | |
| 124,825,000 | |
| 131,999,000 | |
| 135,001,000 | |
| 133,208,000 | |
| 132,833,000 | |
| 139,105,000 | |
| 172,596,000 | |
| 227,971,000 | |
| 273,513,000 | |
| 313,944,000 | |
| 320,454,000 | |
| 302,778,000 | |
| 276,091,000 | |
| 242,807,000 | |
| 215,520,000 | |
| 184,987,000 | |
| 162,551,000 | |
| 141,197,000 | |
| 125,623,000 | |
| 111,850,000 | |
| 104,358,000 | |
| 99,320,000 | |
| 87,770,000 | |
| 76,656,000 | |
| 67,091,000 | |
| 62,276,000 | |
| 56,024,000 | |
| 51,816,000 | |
| 46,757,000 | |
| 37,868,000 | |
| 34,358,000 | |
| 30,701,000 | |
| 28,927,000 | |
| 27,782,000 | |
| 26,452,000 | |
| 25,655,000 | |
| 23,854,000 | |
| 21,929,000 | |
| 19,861,000 | |
| 18,293,000 | |
| 17,370,000 | |
| 16,481,000 | |
| 16,435,000 | |
| 15,601,000 | |
| 14,899,000 | |
| 13,998,000 | |
| 12,007,000 | |
| 12,379,000 | |
| 12,316,000 |